Biosimilars In Limelight On FDA Approval Of Amgen Drug By: TalkMarkets September 27, 2016 at 13:30 PM EDT Late last week, the FDA approved yet another biosimilar product -- biotech giant Amgen Inc.’s Amjevita (adalimumab-atto). Read More >> Related Stocks: AbbVie Amgen CVS Health Corp Eli Lilly Express Scripts Holding Sanofi-Aventis S.A. ADR UnitedHealth Group